Rapid, High-Throughput Single-Cell Multiplex In Situ Tagging (MIST) Analysis of Immunological Disease with Machine

Liwei Yang1, Pratik Dutta2, Ramana V Davuluri2

  • 1Multiplex Biotechnology Laboratory, Department of Biomedical Engineering, State University of New York at Stony Brook, Stony Brook, New York 11794, United States.

Insights

New single-cell multiplex in situ tagging (scMIST) technology analyzes T cells for rapid immunological disorder detection. This approach accurately distinguishes sepsis from normal inflammation, paving the way for advanced diagnostics.

Area of Science:

  • Immunology
  • Single-cell analysis
  • Biotechnology

Background:

  • Immune responses involve complex cytokine cascades, leading to inflammation or sepsis-induced organ damage.
  • Current diagnostic methods for immunological disorders, relying on serum cytokines, lack accuracy and struggle to differentiate normal inflammation from sepsis.
  • There is a critical need for precise diagnostic tools to identify sepsis and other immunological conditions.

Purpose of the Study:

  • To develop and validate a novel approach for detecting immunological disorders using single-cell analysis.
  • To assess the capability of single-cell multiplex in situ tagging (scMIST) technology for ultrahigh-multiplex T cell analysis.
  • To differentiate between normal inflammation and sepsis using T cell profiling.

Main Methods:

  • Employed single-cell multiplex in situ tagging (scMIST) technology for simultaneous detection of 46 markers and cytokines from individual T cells.
  • Utilized a cecal ligation and puncture (CLP) sepsis model in mice, collecting T cells from survivors and non-survivors.
  • Applied a random forest machine learning model for T cell classification and group prediction.

Main Results:

  • scMIST successfully captured T cell features and dynamics during sepsis progression and recovery.
  • T cell markers exhibited distinct dynamics and cytokine levels compared to peripheral blood cytokines.
  • The machine learning model achieved 94% accuracy in predicting mouse groups (sepsis vs. survival) based on single T cell data.

Conclusions:

  • Single-cell multiplex in situ tagging (scMIST) offers a rapid and accurate method for analyzing T cell responses in immunological disorders.
  • This T cell-based approach demonstrates superior potential in distinguishing sepsis from normal inflammation compared to traditional methods.
  • The study pioneers single-cell omics for diagnostics and holds broad applicability for human disease diagnosis and research.

Related Concept Videos